Epicrispr Reports Early Clinical Activity and Favorable Safety Profile in First-in-Human Epigenetic Editing Study for FSHD

Press release originally posted to Business Wire on Thursday, Jan. 8, 2026 at 8:00am. – Company to present at J.P. Morgan Healthcare Conference on Tuesday, Jan 13, 2026 – SAN … Continue reading Epicrispr Reports Early Clinical Activity and Favorable Safety Profile in First-in-Human Epigenetic Editing Study for FSHD